S
Sanjay K Prasad
Researcher at National Institutes of Health
Publications - 363
Citations - 22667
Sanjay K Prasad is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Dilated cardiomyopathy. The author has an hindex of 60, co-authored 338 publications receiving 18463 citations. Previous affiliations of Sanjay K Prasad include Harefield Hospital & University of Miami.
Papers
More filters
Journal ArticleDOI
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
Matthias G. Friedrich,Udo Sechtem,Jeanette Schulz-Menger,Godtfred Holmvang,Pauline Alakija,Leslie T. Cooper,James A. White,Hassan Abdel-Aty,Matthias Gutberlet,Sanjay K Prasad,Anthony H. Aletras,Jean Pierre Laissy,Ian Paterson,Neil G. Filipchuk,Andreas Kumar,Matthias Pauschinger,Peter Liu +16 more
TL;DR: The International Consensus Group on CMR Diagnosis of Myocarditis was founded in 2006 to achieve consensus among CMR experts and develop recommendations on the current state-of-the-art use of CMR for myocarditis.
Journal ArticleDOI
Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium-Enhanced Cardiovascular Magnetic Resonance
Jane McCrohon,James C. Moon,Sanjay K Prasad,William J. McKenna,Christine H. Lorenz,Andrew J.S. Coats,Dudley J. Pennell +6 more
TL;DR: Gadolinium CMR is a powerful technique to distinguish DCM from LV dysfunction related to CAD and yields new insights in DCM, and may become a useful alternative to routine coronary angiography in the diagnostic workup of DCM.
Journal ArticleDOI
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy
Ravi Assomull,Sanjay K Prasad,Jonathan Lyne,Gillian Smith,E. Burman,Mohammed Khan,Mary N. Sheppard,Philip A. Poole-Wilson,Dudley J. Pennell +8 more
TL;DR: In DCM, midwall fibrosis determined by CMR is a predictor of the combined end point of all-cause mortality and cardiovascular hospitalization, which is independent of ventricular remodeling, which suggests a potential role for CMR in the risk stratification of patients with DCM.
Journal ArticleDOI
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Alicia M. Maceira,Jayshree Joshi,Sanjay K Prasad,James C. Moon,Enrica Perugini,Idris Harding,Mary N. Sheppard,Philip A. Poole-Wilson,Philip N. Hawkins,Dudley J. Pennell +9 more
TL;DR: In cardiac amyloidosis, CMR shows a characteristic pattern of global subendocardial late enhancement coupled with abnormal myocardial and blood-pool gadolinium kinetics and may prove to have value in diagnosis and treatment follow-up.
Journal ArticleDOI
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
Ankur Gulati,Andrew Jabbour,Tevfik F Ismail,Kaushik Guha,Jahanzaib Khwaja,Sadaf Raza,Kishen Morarji,Tristan D.H. Brown,Nizar Ismail,Marc R. Dweck,Elisa Di Pietro,Michael Roughton,Ricardo Wage,Yousef Daryani,Rory O'Hanlon,Mary N. Sheppard,Francisco Alpendurada,Alexander R. Lyon,Stuart A. Cook,Martin R. Cowie,Ravi Assomull,Dudley J. Pennell,Sanjay K Prasad +22 more
TL;DR: Risk stratification of patients with nonischemic dilated cardiomyopathy is primarily based on left ventricular ejection fraction (LVEF), and superior prognostic factors may improve patient selection for implantable cardioverter-defibrillators (ICDs) and other management decisions.